Patent · US Active

Modulators of TNF-α signaling

US8921547B2 · kind B2 · utility

1Cited by
40References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 19, 2013
Grant dateDec 30, 2014
Priority date
Expiry dateJul 19, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.